Stocks to watch in the MS drug market
May 26, 2011 at 13:47 PM EDT
A new generation of pills to treat multiple sclerosis is making its way to market, which could be a boon for investors in drug makers like Biogen Idec and Teva.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.